<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940523-2-00056</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4703 -->  <!-- PJG ITAG l=94 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=69 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=50 g=1 f=1 -->   <USDEPT>DEPARTMENT OF HEALTH AND HUMAN SERVICES</USDEPT>  <!-- PJG /ITAG -->  <!-- PJG ITAG l=18 g=1 f=1 -->  <USBUREAU>Food and Drug Administration</USBUREAU> <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=41 g=1 f=1 -->  <RINDOCK>[Docket No. 91A&hyph;0330]</RINDOCK> <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=55 g=1 f=1 --> Calgene, Inc.; Availability of Letter Concluding Consultation <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <AGENCY> <!-- PJG ITAG l=10 g=1 f=2 --> AGENCY:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> Food and Drug Administration, HHS. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline --> </AGENCY> <ACTION> <!-- PJG ITAG l=10 g=1 f=2 --> ACTION:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> Notice. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=59 g=1 f=1 -->  <!-- PJG /ITAG --> </ACTION> <SUMMARY> <!-- PJG ITAG l=10 g=1 f=2 --> SUMMARY:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> The Food and Drug Administration (FDA) is announcing the availability of a letter from FDA to Calgene, Inc., notifying the firm that the agency has concluded that FLAVR SAVR <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=5 f=1 --> TM <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  tomatoes have not been significantly altered when compared to varieties of tomatoes with a history of safe use. FDA also is announcing the availability of a written summary of the consultation between Calgene and the agency concerning FLAVR SAVR <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=5 f=1 --> TM <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  tomatoes, which consultation was conducted in accordance with the agency's policy on foods derived from new plant varieties. FDA is publishing this document to bring to closure the public process that began with a May 1992 notice announcing a request from Calgene for an advisory opinion concerning FLAVR SAVR <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=5 f=1 --> TM <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  tomatoes. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline --> </SUMMARY> <ADDRESS> <!-- PJG ITAG l=10 g=1 f=2 --> ADDRESSES:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> Submit written requests for single copies of the FDA letter and the written summary (free of charge) to the Food and Drug Administration, Center for Food Safety and Applied Nutrition, Biotechnology Policy Branch (HFS&hyph;206), 200 C St. SW., Washington, DC 20204. Requests should be identified with the docket number found in brackets in the heading of this document. Send two self-addressed adhesive labels to assist that office in processing your request. FDA's letter and the written summary are available for public examination in the Dockets Management Branch (HFA&hyph;305), Food and Drug Administration, rm. 1&hyph;23, 12420 Parklawn Dr., Rockville, MD 20857, between 9 a.m. and 4 p.m., Monday through Friday. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline --> </ADDRESS> <FURTHER> <!-- PJG ITAG l=10 g=1 f=2 --> FOR FURTHER INFORMATION CONTACT: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  Linda S. Kahl, Center for Food Safety and Applied Nutrition (HFS&hyph;206), Food and Drug Administration, 200 C St. SW., Washington, DC 20204, 202&hyph;254&hyph;9523. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </FURTHER> <SUPPLEM> <!-- PJG ITAG l=10 g=1 f=2 --> SUPPLEMENTARY INFORMATION:  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=2 --> In a letter dated August 12, 1991, Calgene, Inc., requested an advisory opinion under &sect;10.85 (21 CFR 10.85) concerning whether FLAVR SAVR <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> TM <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  tomatoes are food and, therefore, subject to the same regulation as other tomato varieties. In developing the FLAVR SAVR <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> TM <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  tomato, Calgene used recombinant deoxyribonucleic acid (DNA) techniques to introduce an antisense polygalacturonase (PG) gene. The sense PG gene, normally present in tomatoes, encodes the enzyme PG, which is associated with the breakdown of pectin (a constituent of the cell wall in tomato fruit). The principle underlying the FLAVR SAVR <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> TM <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  tomato is that the antisense PG gene suppresses the production of the PG enzyme, resulting in ripe fruit that remains firm for an extended period, which allows fresh market tomatoes to be vine-ripened for enhanced flavor.  <!-- PJG /ITAG -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=11 g=1 f=1 --> In the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=4 --> Federal Register <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  of May 29, 1992 (57 FR 22984), FDA issued a policy statement (the 1992 policy statement) that clarifies the agency's interpretation of the Federal Food, Drug, and Cosmetic Act (the act) with respect to foods derived from new plant varieties. On that same date, FDA announced Calgene's advisory opinion request (57 FR 22772), and requested public comment. FDA believed that such a notice was in the public interest because that request was the first made to FDA regarding the status of a whole food produced by the new methods of gene transfer.  <!-- PJG 0012 frnewline --> In light of the publication of the 1992 policy statement, FDA now believes that the status of a particular product, such as the FLAVR SAVR <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> TM <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  tomato, should be addressed through a consultation with the agency consistent with the principles outlined in that statement. As a result of that consultation, FDA has notified Calgene, in a letter dated May 17, 1994, that the agency has concluded that FLAVR SAVR <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> TM <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  tomatoes have not been significantly altered when compared to varieties of tomatoes with a history of safe use (21 CFR 170.30(f)(2)). FDA has prepared a written summary of the agency's consultation with Calgene. The written summary includes a response to the comments received on the Calgene advisory opinion request, including comments contained in a citizen petition (Docket No. 92P&hyph;0222/CP1) filed in accordance with &sect;10.30 (21 CFR 10.30). <!-- PJG 0012 frnewline --> FDA believes that this notice brings to closure the public process that began with the agency's announcement of Calgene's advisory opinion request.  <!-- PJG 0012 frnewline --> FLAVR SAVR <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> TM <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  tomatoes contain the kanamycin resistance gene (the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> kan <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> r <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  gene) that encodes the enzyme aminoglycoside-3 <!-- PJG 0020 minuteslatlong --> &rsquo;-phosphotransferase II (APH(3 <!-- PJG 0020 minuteslatlong --> &rsquo;)II). In the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=4 --> Federal Register <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  of July 16, 1993 (58 FR 38429), FDA announced that Calgene had filed a food additive petition (FAP 3A4364) proposing that the food additive regulations be amended to provide for the safe use of APH(3 <!-- PJG 0020 minuteslatlong --> &rsquo;)II as a processing aid in the development of new varieties of tomato, oilseed rape, and cotton. Elsewhere in this issue of the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=4 --> Federal Register <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> , FDA is publishing a final rule that amends the agency's food additive regulations to provide for the safe use of APH(3 <!-- PJG 0020 minuteslatlong --> &rsquo;)II as a processing aid in the development of new varieties of tomato, oilseed rape, and cotton. The agency evaluated the safety of APH(3 <!-- PJG 0020 minuteslatlong --> &rsquo;)II in the context of FAP 3A4364 and not as part of the consultation with Calgene that is the subject of this notice. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=21 g=1 f=1 --> Dated: May 17, 1994. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SUPPLEM> <SIGNER> <!-- PJG ITAG l=06 g=1 f=1 --> Fred R. Shank, <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNER> <SIGNJOB> <!-- PJG ITAG l=04 g=1 f=1 --> Director, Center for Food Safety and Applied Nutrition. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNJOB> <FRFILING> <!-- PJG ITAG l=40 g=1 f=1 --> [FR Doc. 94&hyph;12494 Filed 5&hyph;18&hyph;94; 12:39 pm] <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </FRFILING> <BILLING> <!-- PJG ITAG l=68 g=1 f=1 --> BILLING CODE 4160&hyph;01&hyph;F <!-- PJG /ITAG --> </BILLING>  <!-- PJG /STAG --></p>
		</main>
</body></html>
            